Strata Critical Medical (SRTA) accounting chief sells 4,655 shares in open market

Rhea-AI Filing Summary

Strata Critical Medical, Inc. Chief Accounting Officer Cohen Amir reported an open-market sale of Class A common stock. On June 8, 2026, he sold 4,655 shares at $5.87 per share. After this transaction, he directly holds 146,608 shares of the company’s common stock.

Insider Trade Summary

Net Seller: 4,655 shares ($27,325)

Net Sell 1 txn

Insider Cohen Amir

Role Chief Accounting Officer

Sold 4,655 shs ($27K)

Type	Security	Shares	Price	Value
Sale	Class A common stock, $0.0001 par value per share	4,655	$5.87	$27K

Holdings After Transaction: Class A common stock, $0.0001 par value per share — 146,608 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 4,655 shares Sale price: $5.87 per share Shares held after transaction: 146,608 shares +2 more

5 metrics

Shares sold 4,655 shares Open-market sale on June 8, 2026

Sale price $5.87 per share Class A common stock transaction

Shares held after transaction 146,608 shares Direct ownership following sale

Security type Class A common stock, $0.0001 par value Non-derivative equity security

Transaction code S Sale in open market or private transaction

Key Terms

open-market sale, Class A common stock, Form 4, restricted stock units, +1 more

5 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Class A common stock financial

"security_title": "Class A common stock, $0.0001 par value per share""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

restricted stock units financial

"vesting of restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Chief Accounting Officer financial

"officer_title": "Chief Accounting Officer""

A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/10/2026 - 04:06 PM Accepted by SEC EDGAR 06/10/2026 - 04:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cohen Amir

(Last) (First) (Middle)

C/O STRATA CRITICAL MEDICAL, INC.

666 THIRD AVENUE, 25TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock, $0.0001 par value per share	06/08/2026		S		4,655(1)	D	$5.87	146,608	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Melissa M. Tomkiel, Attorney-in-fact for Amir Cohen	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Strata Critical Medical (SRTA) report for Cohen Amir?

Strata Critical Medical reported that Chief Accounting Officer Cohen Amir sold 4,655 shares of Class A common stock. The transaction was an open-market sale and is disclosed in a Form 4 insider trading report.

How many Strata Critical Medical (SRTA) shares did Cohen Amir sell and at what price?

Cohen Amir sold 4,655 shares of Strata Critical Medical Class A common stock. The reported sale price was $5.87 per share in an open-market transaction on June 8, 2026.

How many Strata Critical Medical (SRTA) shares does Cohen Amir hold after the sale?

Following the reported transaction, Cohen Amir directly holds 146,608 shares of Strata Critical Medical Class A common stock. This figure reflects his position after selling 4,655 shares in the open market.

What is the role of Cohen Amir at Strata Critical Medical (SRTA)?

Cohen Amir serves as Chief Accounting Officer at Strata Critical Medical. His position makes his equity transactions reportable on Form 4, providing transparency into insider ownership and trading activity for investors.

Was the Strata Critical Medical (SRTA) insider transaction an open-market sale?

Yes. The Form 4 describes the transaction as an open-market sale of Class A common stock. The sale involved 4,655 shares at a price of $5.87 per share on June 8, 2026.